Genmab A/S (GMAB) Announces Submissions of Regulatory Applications for Epcoritamab for Relapsed/Refractory LBCL and DLBCL

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. AAPL
6. ONON
7. AZN
8. TRMD
9. NVDA
10. RARE

Go back to Genmab A/S (GMAB) Announces Submissions of Regulatory Applications for Epcoritamab for Relapsed/Refractory LBCL and DLBCL
AbbVie (NYSE: ABBV) Delayed: 263.77 -0.25 (0.09%)
Previous Close $264.02    52 Week High $68.12 
Open $263.29    52 Week Low $50.71 
Day High $266.34    P/E 57.22 
Day Low $262.44    EPS $4.61 
Volume 1,448,797       

(NASDAQ: GMAB) Delayed: 34.90 +0.37 (1.07%)
Previous Close $34.53    52 Week High $ 
Open $34.92    52 Week Low $ 
Day High $35.15    P/E N/A 
Day Low $34.75    EPS $ 
Volume 536,471